reference/24847536

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24847536

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
issn	1745-6215 1468-6708
issueIdentifier	1
pageRange	87-
publicationName	Trials
startingPage	87
bibliographicCitation	Lee SP, Suh JW, Park KW, Lee HY, Kang HJ, Koo BK, Chae IH, Choi DJ, Rha SW, Bae JW, Cho MC, Kwon TG, Bae JH, Kim HS; CILON-T investigators. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease. Trials. 2010 Aug 24;11():87. PMID: 20735821; PMCID: PMC2936395.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9521-4102 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f1e0b68e341dd74d5b5ddd2cb4670f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b98675c3802fdd0732840d6a22a0fea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b71ca2d8fed954d1fe150e36cb54ccdf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b6ad64a037c94fed06c6526be10f8ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9456-9852 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bf4564c65a6592bf6a0677af1241cc5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3500-1746 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d36867c86ddce35f3e2dabc6415a9509 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f94b5f26ba4d650531926ef40752409 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6299b016ff8ea290238b197a4b7b05d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82fc155b6e79b2cf7229e82904da20cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8edf072a2e77851eb580b1808fa6cbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c25d5f055f4dbde9dcfbb68d31caecb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbf9071096ea3199ef0295441f0510f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28bf2e1f5a5032fc186f91485e7eef7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c1c46ebfeb0f0a69625e00acbf7f13b
date	2010-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/1745-6215-11-87 https://pubmed.ncbi.nlm.nih.gov/20735821 https://pubmed.ncbi.nlm.nih.gov/PMC2936395
isPartOf	https://portal.issn.org/resource/ISSN/1745-6215 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26742 https://portal.issn.org/resource/ISSN/1468-6708 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32804
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease
discusses	http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M0132637 http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0017012
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45114162 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7224 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87071853 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7347 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12086784 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9585 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2754 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9869776 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_73717aafac1e7701dab0fa02b8936926

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136137898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129170378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129352157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926582

Total number of triples: 75.